News By/Courtesy: Sonal Gupta | 02 Dec 2018 12:13pm IST

HIGHLIGHTS

  • U.S. court permitting Dr. Reddy’s to sell a generic version of British drugmaker Indivior’s opioid dependence treatment drug Suboxone.
  • The United States Court of Appeals for the Federal Circuit issued a decision in favour of Dr. Reddy’s Laboratories Inc .
  • As a result of the ruling, Dr. Reddy’s said it will resume the launch activities, for the generic drug, as soon as permitted.

 U.S. court permitting Dr. Reddy’s to sell a generic version of British drugmaker Indivior’s opioid dependence treatment drug Suboxone. The United States Court of Appeals for the Federal Circuit issued a decision in favour of Dr. Reddy’s Laboratories Inc . As a result of the ruling, Dr. Reddy’s said it will resume the launch activities, for the generic drug, as soon as permitted. The US Food and Drug Administration (USFDA) approved Dr.Reddy’s Buprenorphine and Naloxone Sublingual Film for sale in the U.S. market.

Section Editor: Priyanshu Gupta | 02 Dec 2018 12:17pm IST


Tags : #US Court#Permission Granted#Generic Drug

Latest News

























5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice


Copyright Kalyan Krishna MediaZ Private Limited. All rights reserved. Unless otherwise indicated, all materials on these pages are copyrighted by Kalyan Krishna MediaZ Private Limited. All rights reserved. No part of these pages, either text or image may be used for any purpose. By continuing past this page, you agree to our Terms of Service, Cookie Policy, Privacy Policy and Content Policies.